Hexo Corp
TSX:HEXO
Hexo Corp
TSX:HEXO
Price:
0.88
CAD
1.15%
Market Closed
Market Cap:
CA$38.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Hexo Corp
TSX:HEXO
|
CA |
|
C
|
Cyfrowe Centrum Serwisowe SA
WSE:CCS
|
PL |
|
M
|
Mazhar Zorlu Holding AS
IST:MZHLD.E
|
TR |
|
Netex Knowledge Factory SA
MAD:NTX
|
ES |
|
Skandinaviska Enskilda Banken AB
STO:SEB A
|
SE |
|
Midatech Pharma PLC
LSE:MTPH
|
UK |
|
Shaanxi Heimao Coking Co Ltd
SSE:601015
|
CN |
|
L
|
Lumir Inc
KOSDAQ:474170
|
KR |
|
Fleury SA
BOVESPA:FLRY3
|
BR |
|
F
|
First Physicians Capital Group Inc
OTC:FPCG
|
US |
|
CoreCivic Inc
NYSE:CXW
|
US |
|
Waste Connections Inc
TSX:WCN
|
CA |
|
C
|
Canadian Net Real Estate Investment Trust
XTSX:NET.UN
|
CA |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of HEXO.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
HEXO
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
HEXO Competitors Multiples
Hexo Corp Competitors
Hexo Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Hexo Corp
TSX:HEXO
|
38.7m CAD | 0.3 | -0.1 | -1.9 | -1.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD | 12.7 | 40.2 | 27.2 | 29 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.5 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD | 4.6 | 16.2 | 10 | 12.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF | 5.2 | 21.1 | 13 | 16.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.5B GBP | 5.1 | 29.1 | 16.1 | 22.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 9.8 | 7.3 | 8.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD | 2.4 | 16.7 | 7.1 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
